Literature DB >> 27580516

Assessment of the patellofemoral cartilage: Correlation of knee pain score with magnetic resonance cartilage grading and magnetization transfer ratio asymmetry of glycosaminoglycan chemical exchange saturation transfer.

Young Han Lee1, Jaemoon Yang1, Ha-Kyu Jeong2, Jin-Suck Suh3.   

Abstract

PURPOSE: Biochemical imaging of glycosaminoglycan chemical exchange saturation transfer (gagCEST) could predict the depletion of glycosaminoglycans (GAG) in early osteoarthritis. The purpose of this study was to evaluate the relationship between the magnetization transfer ratio asymmetry (MTRasym) of gagCEST images and visual analog scale (VAS) pain scores in the knee joint.
MATERIALS AND METHODS: This retrospective study was approved by the institutional review board. A phantom study was performed using hyaluronic acid to validate the MTRasym values of gagCEST images. Knee magnetic resonance (MR) images of 22 patients (male, 9; female, 13; mean age, 50.3years; age range; 25-79years) with knee pain were included in this study. The MR imaging (MRI) protocol involved standard knee MRI as well as gagCEST imaging, which allowed region-of-interest analyses of the patellar facet and femoral trochlea. The MTRasym at 1.0ppm was calculated at each region. The cartilages of the patellar facets and femoral trochlea were graded according to the Outerbridge classification system. Data regarding the VAS scores of knee pain were collected from the electronic medical records of the patients. Statistical analysis was performed using Spearman's correlation.
RESULTS: The results of the phantom study revealed excellent correlation between the MTRasym values and the concentration of GAGs (r=0.961; p=0.003). The cartilage grades on the MR images showed significant negative correlation with the MTRasym values in the patellar facet and femoral trochlea (r=-0.460; p=0.031 and r=-0.543; p=0.009, respectively). The VAS pain scores showed significant negative correlation with the MTRasym values in the patellar facet and femoral trochlea (r=-0.435; p=0.043 and r=-0.671; p=0.001, respectively).
CONCLUSION: The pain scores were associated with the morphological and biochemical changes in articular cartilages visualized on knee MR images. The biochemical changes, visualized in terms of the MTRasym values of the gagCEST images, exhibited greater correlation with the pain scores than the morphological changes visualized on conventional MR images; these results provide evidence supporting the theory regarding the association of patellofemoral osteoarthritis with knee pain scores. Copyright Â
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cartilage; Chemical exchange saturation transfer; Magnetic resonance imaging (MRI); Magnetization transfer contrast imaging

Mesh:

Substances:

Year:  2016        PMID: 27580516     DOI: 10.1016/j.mri.2016.08.014

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  4 in total

Review 1.  Chemical exchange saturation transfer magnetic resonance imaging and its main and potential applications in pre-clinical and clinical studies.

Authors:  Weiqiang Dou; Chien-Yuan Eddy Lin; Hongyuan Ding; Yong Shen; Carol Dou; Long Qian; Baohong Wen; Bing Wu
Journal:  Quant Imaging Med Surg       Date:  2019-10

Review 2.  Clinical applications of chemical exchange saturation transfer (CEST) MRI.

Authors:  Kyle M Jones; Alyssa C Pollard; Mark D Pagel
Journal:  J Magn Reson Imaging       Date:  2017-08-09       Impact factor: 4.813

3.  Influence of phosphate concentration on amine, amide, and hydroxyl CEST contrast.

Authors:  Jingwen Yao; Chencai Wang; Benjamin M Ellingson
Journal:  Magn Reson Med       Date:  2020-09-16       Impact factor: 3.737

4.  Induction of osteoarthritis by injecting monosodium iodoacetate into the patellofemoral joint of an experimental rat model.

Authors:  Ikufumi Takahashi; Taro Matsuzaki; Hiroshi Kuroki; Masahiro Hoso
Journal:  PLoS One       Date:  2018-04-26       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.